News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
333,490 Results
Type
Article (19991)
Company Profile (138)
Press Release (313361)
Section
Business (106239)
Career Advice (877)
Deals (18668)
Drug Delivery (93)
Drug Development (51080)
Employer Resources (79)
FDA (7769)
Job Trends (7806)
News (187290)
Policy (17464)
Tag
Academia (768)
Alliances (28043)
Alzheimer's disease (619)
Antibody-drug conjugate (ADC) (67)
Approvals (7753)
Artificial intelligence (97)
Bankruptcy (174)
Best Places to Work (5608)
Biosimilars (73)
Breast cancer (91)
Cancer (780)
Cardiovascular disease (79)
Career advice (710)
Cell therapy (113)
Clinical research (42419)
Collaboration (324)
Compensation (112)
COVID-19 (1101)
C-suite (88)
Data (813)
Diabetes (115)
Diagnostics (1784)
Drug pricing (99)
Earnings (38601)
Employer resources (73)
Events (48618)
Executive appointments (309)
FDA (8154)
Funding (230)
Gene therapy (108)
GLP-1 (527)
Government (1843)
Healthcare (6077)
Infectious disease (1159)
Inflammatory bowel disease (75)
Interviews (115)
IPO (7391)
Job creations (2444)
Job search strategy (647)
Layoffs (260)
Legal (4118)
Lung cancer (123)
Manufacturing (154)
Medical device (2132)
Medtech (2135)
Mergers & acquisitions (11408)
Metabolic disorders (391)
Neuroscience (837)
NextGen: Class of 2025 (2419)
Non-profit (989)
Northern California (833)
Obesity (251)
Opinion (180)
Patents (90)
People (33509)
Pharmaceutical (78)
Phase I (13275)
Phase II (17959)
Phase III (14413)
Pipeline (380)
Policy (78)
Postmarket research (1620)
Preclinical (4647)
Radiopharmaceuticals (157)
Rare diseases (178)
Real estate (3197)
Regulatory (12374)
Research institute (860)
Resumes & cover letters (139)
Southern California (769)
Startups (2028)
United States (7639)
Vaccines (229)
Weight loss (207)
Date
Today (74)
Last 7 days (210)
Last 30 days (991)
Last 365 days (17677)
2025 (887)
2024 (17880)
2023 (19887)
2022 (26175)
2021 (26984)
2020 (25207)
2019 (20414)
2018 (15835)
2017 (17413)
2016 (16382)
2015 (19045)
2014 (14977)
2013 (12689)
2012 (13585)
2011 (13950)
2010 (12841)
Location
Africa (417)
Asia (24795)
Australia (3229)
California (1903)
Canada (896)
China (223)
Colorado (78)
Connecticut (77)
Europe (51198)
Florida (291)
Illinois (193)
Indiana (140)
Japan (77)
Maryland (280)
Massachusetts (1617)
Minnesota (108)
New Jersey (724)
New York (547)
North Carolina (407)
Northern California (833)
Ohio (69)
Pennsylvania (448)
South America (610)
Southern California (769)
Texas (256)
Washington State (172)
333,490 Results for "leo pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
January 20, 2025
·
8 min read
Press Releases
Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
January 13, 2025
·
6 min read
Press Releases
LEO Pharma’s Anzupgo® (delgocitinib) Cream Achieves Marketing Approval in Switzerland
November 14, 2024
·
11 min read
Press Releases
Germany Becomes the First Country to Launch LEO Pharma’s Anzupgo® (delgocitinib) Cream
October 15, 2024
·
8 min read
Press Releases
LEO Pharma Submits New Drug Application for Enstilar® for Adults with Plaque Psoriasis in China
September 27, 2024
·
6 min read
Press Releases
LEO Pharma Presents Adbry® (tralokinumab-ldrm) and Delgocitinib Cream Data at 2024 Fall Clinical Dermatology Conference
October 23, 2024
·
16 min read
Press Releases
FDA Accepts LEO Pharma’s Filing of Delgocitinib Cream New Drug Application for the Treatment of Chronic Hand Eczema
September 23, 2024
·
10 min read
Immunology and inflammation
Gilead Continues Diversification Drive With Potential $1.7B Inflammation Pact With LEO
Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 and IL-13 signaling, which in turn are known inflammatory targets.
January 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
European Commission Approves LEO Pharma’s Anzupgo® (delgocitinib) Cream for Adults with Moderate to Severe Chronic Hand Eczema (CHE)
September 23, 2024
·
9 min read
Pharm Country
LEO Pharma Presents Data at 2024 Winter Clinical and Maui Derm Conferences
LEO Pharma A/S, a global leader in medical dermatology, will present a catalog of investigational delgocitinib cream and Adbry® data across 10 posters at the upcoming Winter Clinical and Maui Derm conferences this month.
January 12, 2024
·
14 min read
1 of 33,349
Next
